BEONE MEDICINES LTD. (BEIGF) Capital expenditures 2016–2025
BEONE MEDICINES LTD. (BEIGF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$185.8MFY2025 · since FY2016: $23.5M → $185.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $185.8M | -62.3% |
| FY2024 | $492.7M | -12.3% |
| FY2023 | $561.9M | +72.7% |
| FY2022 | $325.4M | +23.8% |
| FY2021 | $262.9M | +123.8% |
| FY2020 | $117.5M | +31.1% |
| FY2019 | $89.6M | +27.5% |
| FY2018 | $70.3M | +51.6% |
| FY2017 | $46.4M | +97.3% |
| FY2016 | $23.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Net marginBEIGF Gross profitBEIGF Gross marginBEIGF Operating incomeBEIGF Operating marginBEIGF Operating cash flowBEIGF Free cash flowBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →